Fieldview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$5.89M |
| 2 |
Netflix
NFLX
|
+$5.6M |
| 3 |
Best Buy
BBY
|
+$5.27M |
| 4 |
Dick's Sporting Goods
DKS
|
+$4.52M |
| 5 |
Adobe
ADBE
|
+$4.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royal Gold
RGLD
|
+$8.7M |
| 2 |
Oracle
ORCL
|
+$8.69M |
| 3 |
Walt Disney
DIS
|
+$5.83M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$5.77M |
| 5 |
Boston Scientific
BSX
|
+$5.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.11% |
| 2 | Technology | 18.12% |
| 3 | Financials | 17.99% |
| 4 | Industrials | 11.7% |
| 5 | Healthcare | 10.13% |
Similar funds
Fieldview Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Fieldview Capital Management held 684 positions worth $589M, down 3.7% from $612M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Fieldview Capital Management withdrew a net $19.2M in Q4 2025, closing 212 positions and reducing 83 holdings. Its most notable exit was Royal Gold, an estimated $8.7M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Fieldview Capital Management opened a new position in UnitedHealth worth $5.74M.
- Fieldview Capital Management's largest Q4 2025 buy was UnitedHealth: 17,389 shares worth $5.74M.
- Fieldview Capital Management added most to Garmin in Q4 2025, an estimated $4.15M increase.
- Fieldview Capital Management's biggest Q4 2025 reduction was Accenture, cutting an estimated $4.29M.
- Fieldview Capital Management fully exited Royal Gold in Q4 2025, selling an estimated $8.7M.
- Fieldview Capital Management's ten largest holdings make up 10% of its $589M portfolio in Q4 2025.
- Fieldview Capital Management opened 301 new positions and closed 212 in Q4 2025.
- Fieldview Capital Management's portfolio value fell 3.7% quarter-over-quarter to $589M.
Based on Fieldview Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.